Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2006 Filed Feb 1, 2007 02:46 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 1,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006244 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,154 Read SEC document |
| December 06, 2006 Filed Feb 3, 2007 01:26 UTC |
Landgraf John CSenior Vice President
|
GiftCommon shares without par value | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006983 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,385 Read SEC document |
| December 03, 2006 Filed Dec 5, 2006 21:58 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Tax withholdingCommon shares without par value | 3,156 | $46.60 | $147,069.60 |
DisclosureSEC source: 0001104659-06-079537 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,956 Read SEC document |
| December 01, 2006 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GiftCommon shares without par value | 2,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · nonDerivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,191 Read SEC document |
| November 29, 2006 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GiftCommon shares without par value | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,307 Read SEC document |
| November 01, 2006 Filed Nov 3, 2006 22:01 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantCommon shares without par value | 20,000 | $47.36 | $947,200.00 |
DisclosureSEC source: 0001104659-06-071267 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,798 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| October 27, 2006 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GiftCommon shares without par value | 945 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,627 Read SEC document |
| October 15, 2006 Filed Oct 17, 2006 20:41 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon Shares without par value | 1,704 | $46.72 | $79,610.88 |
DisclosureSEC source: 0001104659-06-067062 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,390 Read SEC document |
| October 03, 2006 Filed Aug 12, 2008 23:50 UTC |
Chen Thomas FSenior Vice President
|
GiftCommon shares without par value | 461 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-052315 · a4.xml · nonDerivative · entry 6 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 2,937 Read SEC document |
| October 03, 2006 Filed Aug 12, 2008 23:50 UTC |
Chen Thomas FSenior Vice President
|
GiftCommon shares without par value | 461 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-052315 · a4.xml · nonDerivative · entry 2 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,107 Read SEC document |
| October 01, 2006 Filed Oct 3, 2006 21:00 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 15,780 | $48.37 | $763,199.70 |
DisclosureSEC source: 0001104659-06-064641 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 817,419 Read SEC document |
| September 30, 2006 Filed Oct 3, 2006 20:59 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 257 | $48.56 Strike: $0.00 | $12,479.92 |
DisclosureSEC source: 0001104659-06-064638 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,752 Underlying: common shares · 257 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2006 Filed Oct 3, 2006 20:59 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 504 | $48.56 Strike: $0.00 | $24,474.24 |
DisclosureSEC source: 0001104659-06-064639 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,576 Underlying: common shares · 504 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2006 Filed Oct 3, 2006 21:00 UTC |
DALEY WILLIAM MDirector
|
GrantStock equivalent units · Derivative | 411 | $48.56 Strike: $0.00 | $19,958.16 |
DisclosureSEC source: 0001104659-06-064640 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,516 Underlying: common shares · 411 shares Expires not disclosed F1 · derivative.exercise_price: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by the him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by the him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: This director defers and credits director fees to a stock equivalent unit account under a grantor trust established by the him and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 22, 2006 Filed Sep 26, 2006 22:00 UTC |
WALTER JOHN RDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,796 | $0.00 Strike: $24.20 | $0.00 |
DisclosureSEC source: 0001104659-06-063205 · a4.xml · derivative · entry 6 WALTER JOHN R · CIK 0001046302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,796 shares Expires 2006-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. Read SEC document |
| September 22, 2006 Filed Sep 26, 2006 22:00 UTC |
WALTER JOHN RDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,870 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001104659-06-063205 · a4.xml · derivative · entry 5 WALTER JOHN R · CIK 0001046302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,870 shares Expires 2006-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. Read SEC document |
| September 22, 2006 Filed Sep 26, 2006 22:00 UTC |
WALTER JOHN RDirector
|
Exercise / conversionCommon shares without par value | 1,796 | $24.20 | $43,463.02 |
DisclosureSEC source: 0001104659-06-063205 · a4.xml · nonDerivative · entry 2 WALTER JOHN R · CIK 0001046302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2006 Filed Sep 26, 2006 22:00 UTC |
WALTER JOHN RDirector
|
Exercise / conversionCommon shares without par value | 1,870 | $23.23 | $43,443.65 |
DisclosureSEC source: 0001104659-06-063205 · a4.xml · nonDerivative · entry 1 WALTER JOHN R · CIK 0001046302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2006 Filed Sep 15, 2006 21:00 UTC |
POWELL BOONE JRDirector
|
SaleCommon shares without par value | 1,000 | $49.10 | $49,100.00 |
DisclosureSEC source: 0001104659-06-061447 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,045 Read SEC document |
| August 25, 2006 Filed Aug 28, 2006 21:22 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,058 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-06-057622 · a4.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 5,058 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 25, 2006 Filed Aug 28, 2006 21:22 UTC |
Schumacher Laura JSenior Vice President
|
Tax withholdingCommon shares without par value | 2,842 | $48.82 | $138,746.44 |
DisclosureSEC source: 0001104659-06-057622 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,347 Read SEC document |
| August 25, 2006 Filed Aug 28, 2006 21:22 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,058 | $27.43 | $138,755.10 |
DisclosureSEC source: 0001104659-06-057622 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 825 | $0.00 Strike: $49.00 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 14 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 Underlying: common shares · 825 shares Expires 2008-02-12 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 7,726 | $0.00 Strike: $49.00 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 13 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,726 Underlying: common shares · 7,726 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 2,039 | $0.00 Strike: $49.00 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 12 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,039 Underlying: common shares · 2,039 shares Expires 2010-02-10 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,163 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 11 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,954 Underlying: common shares · 1,163 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,077 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,393 Underlying: common shares · 10,077 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,065 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,065 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Tax withholdingCommon shares without par value | 10,590 | $49.00 | $518,910.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,112 Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 1,163 | $34.77 | $40,440.65 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 10,077 | $33.23 | $334,872.82 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon shares without par value | 3,065 | $32.61 | $99,953.02 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2006 Filed Sep 14, 2006 18:58 UTC |
LINDER GREG WVice President
|
GiftCommon shares without par value | 65 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-061117 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,094 Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:17 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantOption (right to buy) · Derivative | 2,082 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-06-056022 · a4.xml · derivative · entry 8 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,082 Underlying: common shares · 2,082 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:17 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantOption (right to buy) · Derivative | 2,054 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-06-056022 · a4.xml · derivative · entry 7 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,054 Underlying: common shares · 2,054 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:17 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,050 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-056022 · a4.xml · derivative · entry 6 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,050 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:17 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,065 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-06-056022 · a4.xml · derivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,065 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:17 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Tax withholdingCommon shares without par value | 4,136 | $48.66 | $201,257.76 |
DisclosureSEC source: 0001104659-06-056022 · a4.xml · nonDerivative · entry 3 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,798 Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:17 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,050 | $33.23 | $101,355.77 |
DisclosureSEC source: 0001104659-06-056022 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:17 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,065 | $32.61 | $99,953.02 |
DisclosureSEC source: 0001104659-06-056022 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
GrantOption (right to buy) · Derivative | 16,165 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 14 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,165 Underlying: common shares · 16,165 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
GrantOption (right to buy) · Derivative | 2,054 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 13 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,054 Underlying: common shares · 2,054 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 20,005 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 12 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 20,005 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,653 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 11 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,653 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,831 | $0.00 Strike: $43.99 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 10 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,831 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,553 | $0.00 Strike: $39.92 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 9 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 5,553 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · derivative · entry 8 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Tax withholdingCommon shares without par value | 28,081 | $48.66 | $1,366,421.46 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 6 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,005 Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionCommon shares without par value | 20,005 | $33.23 | $664,794.16 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 5 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,653 | $40.74 | $108,083.22 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 4 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.